Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease

Bone

Volumn 48, Issue 6, 2011, Pages 1260-1267

  Iwasaki, Yoshiko ^a   Kazama, Junichiro James ^b   Yamato, Hideyuki ^c   Fukagawa, Masafumi ^d  

^a OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c KUREHA CORPORATION   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone mechanical property; Chemical composition; Chronic kidney disease

Indexed keywords

ENZYME; PENTOSIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; BIOMECHANICS; BONE DENSITY; BONE FRAGILITY; BONE MATRIX; BONE STRUCTURE; BONE TISSUE; CANCELLOUS BONE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORTICAL BONE; FEMUR; IN VIVO STUDY; MALE; MORPHOMETRICS; NONHUMAN; RAT;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE AND BONES; BONE DENSITY; DISEASE MODELS, ANIMAL; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPECTRUM ANALYSIS, RAMAN;

EID: 79955903606     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.03.672     Document Type: Article

References (56)

1. Alem A.M., Sherrard D.J., Gillen D.L., Weiss N.S., Beresfold S.A., Heckbert S.R., et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000, 58:396-399.
2. CoCo M., Rush H. Increased incidence of hip fracture s in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000, 36:1115-1121.
3. Nickolas T.L., Mcmahon D.J., Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 2006, 17:3223-3232.
4. Ensrud K.E., Lui L.Y., Taylor B.C., Ishani A., Shlipak M.G., Stone K.L., Osteoporotic Fracture Research Group, et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007, 167:133-139.
5. Jamal S.A., Bauer D.C., Ensrud K.E., Cauley J.A., Hochberg M., Ishani A., et al. Alendronate treatment in women with normal to severe renal impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 2007, 22:503-508.
6. Fried L.F., Biggs M.L., Shlipak M.G., Seliger S., Kestenbaum B., Stehman-Breen C., et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 2007, 18:282-286.
7. Dooley A.C., Weiss N.S., Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008, 51:38-44.
8. Mittalhenkle A., Gillen D.L., Stehman-Breen C.O. Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 2004, 44:672-679.
9. Nitsch D., Mylne A., Roderick P.J., Smeeth L., Hubbard R., Fletcher A. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant 2009, 24:1539-1544.
10. Jassal S.K., Muhlen D., Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo Study. J Bone Miner Res 2007, 22:203-210.
11. Fusaro M., D'Angel A., Scalzo G., Gallieni M., Giannini S., Guglielmi G. Vertebral fractures in dialysis: endocrinological disruption of the bone-kidney axis. J Endocrinol Invest 2010, 33:347-352.
12. Parfitt A.M. A structural approach to renal bone disease. J Bone Miner Res 1998, 13:1213-1220.
13. Rudse K.D., de Boer I.H., Dooley A., Young B., Kestenbaum B. Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 2007, 18:2401-2407.
14. Nakai S., Masakane I., Shigematsu T., Hamano T., Yamagata K., Watanabe Y., Itami N., Ogata S., Kimata N., Shinoda T., Shoji T., Suzuki K., Taniguchi M., Tsuchida K., Nakamoto H., Nishi S., Nishi H., Hashimoto S., Hasegawa T., Hanafusa N., Fujii N., Marubayashi S., Morita O., Wakai K., Wada A., Iseki K., Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010, 14:505-540.
15. Seeman E., Delmas P.D. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 2006, 354:2250-2261.
16. Fratzl P., Gupta H.S., Paschalis E.P., Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem 2004, 14:2115-2123.
17. Weiner S., Wagner H.D. The material bone: structure-mechanical function relations. Annu Rev Mater Sci 1998, 28:271-298.
18. Yerramshetty J.S., Akkus O. The associations between mineral crystallinity and the mechanical properties of human cortical bone. Bone 2008, 42:476-482.
19. McCreadie B.R., Morris M.D., Chen T.C., Sudhaker Rao D., Finney W.F., Widjaja E., et al. Bone tissue compositional differences in women with and without osteoporotic fracture. Bone 2006, 39:1190-1195.
20. Iwasaki-Ishizuka Y., Yamato H., Nii-kono T., Kurokawa K., Fukagawa M. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 2005, 20:1904-1911.
21. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
22. Menard K.P. Dynamic mechanical analysis: a practical introduction 2008, 1-15. CRC Press, New York.
23. Faibish D., Ott S.M., Boskey A.L. Mineral changes in osteoporosis: a review. Clin Orthop Relat Res 2006, 443:28-38.
24. Yerramshetty J.S., Lind C., Akkus O. The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. Bone 2006, 29:1236-1243.
25. Carden A., Rajachar R.M., Morris M.D., Kohn D.H. Ultrastructural changes accompanying the mechanical deformation of bone tissue: a Raman imaging study. Calcif Tissue Int 2003, 72:166-175.
26. Miyazaki K., Nagai R., Horiuchi S. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product. J Biochem 2002, 132:543-550.
27. Glenn J.V., Beattie J.R., Barrett L., Frizzell N., Thorpe S.R., Boulton M.E., et al. Confocal Raman microscopy ca quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging. FASEB J 2007, 21:3542-3552.
28. Tarnowski C.P., Ignelzi M.A., Morris M.D. Mineralization of developing mouse calvaria as revealed by Raman microspectroscopy. J Bone Miner Res 2002, 17:1118-1126.
29. Carter D.R., Hays W.C. The compressive behavior of bone as a two-phase porous structure. J Bone Joint Surg Am 1997, 59:954-962.
30. Garner E., Lakes R., Lee T., Swan C., Brand R. Viscoelastic dissipation in compact bone: implications for stress-induced fluid flow in bone. J Biomech Eng 2000, 122:166-172.
31. McElhaney J.H. Dynamic response to bone and muscle tissue. J Appl Physiol 1966, 21:1231-1236.
32. Currey J.D. Strain rate and mineral content in fracture models of bone. J Orthop Res 1988, 6:32-38.
33. Robertson D.M., Smith D.C. Compressive strength of mandibular bone as a function of microstructure and strain rate. J Biomech 1987, 11:455-457.
34. Coutney A.C., Wachtel E.F., Myers E.R., Hayes W.C. Effect of loading rate on strength of the proximal femur. Calcif Tissue Int 1994, 55:53-58.
35. Yamashita J., Furman B.R., Rawls H.R., Wang X., Agrawal C.M. The use of dynamic mechanical analysis to assess the viscoelastic properties of human cortical bone. J Biomed Mater Res 2001, 59:47-53.
36. Yeni Y.N., Shaffer R., Baker K.C., Dong X.N., Grimm M.J., Les C.M., et al. The effect of yield damage on the viscoelastic properties of cortical bone tissue as measured by dynamic mechanical analysis. J Biomed Mater Res 2007, 82:530-537.
37. Kazama J.J., Koda R., Yamamoto S., Narita I., Gejyo F., Tokumoto A. Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients. Clin J Am Soc Nephrol 2010, 5:292-298.
38. Kaji H., Yamauchi M., Yamaguchi T., Shigematsu T., Sugimoto T. Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women. J Clin Endocrinol Metab 2010, 95:4635-4642.
39. Gourion-Arsiquaud S., Burket J.C., Havill L.M., DiCarlo E., Doty S.B., Mendelsohn R., et al. Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res 2009, 24:1271-1281.
40. Boskey A.L., Spevak L., Weinstein R.S. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int 2009, 20:793-800.
41. Gourion-Arsiquaud S., Faibish D., Myers E., Spevak L., Compston J., Hodsman A., et al. Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res 2009, 24:1565-1571.
42. Akkus O., Adar F., Shaffler M.B. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone 2004, 34:443-453.
43. Akkus O., Akkus-Polyakova A., Adar F., Schaffler M. Aging of microstructural compartments in human compact bone. J Bone Miner Res 2003, 18:1012-1019.
44. Paschalis E.P., Shane E., Lyritis G., Skarantavos G., Mendelsohn R., Boskey A.L. Bone fragility and collagen cross-links. J Bone Miner Res 2004, 19:2000-2004.
45. Saito M., Fujii K., Soshi S., Tanaka T. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 2006, 17:986-995.
46. Saito M., Fujii K., Mori Y., Karumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 2006, 17:1514-1523.
47. Saito M., Fujii K., Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006, 79:160-168.
48. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 2010, 21:195-214.
49. Yamamoto M., Yamaguchi T., Yano S., Sugimoto T. Serum pentosidine are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2008, 93:10013-11919.
50. Shiraki M., Kuroda T., Tanaka S., Saito M., Fukunaga M., Nakamura T. Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 2008, 26:93-100.
51. Schwartz A.V., Garnero P., Hillier T.A., Sellmeyer D.E., Strotmeyer E.S., Feingold K.R., et al. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 2009, 94:2380-2386.
52. Hernandez C., Tang S.Y., Baumbach B.M., Hwu P.B., Sakkee A.N., van der Ham F., et al. Trabecular microfracture and influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 2005, 37:825-832.
53. Viguet-Carrin S., Roux J.P., Arlot M.E., Merabet Z., Leeming D.J., Byrjalsen I., et al. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 2006, 39:1073-1079.
54. McCarthy A.D., Etcheverry S.B., Bruzzone L., Lettieri G., Barrio D.A., Cortizo A.M. Non-enzymatic glycation of type I collagen matrix: effect on osteoblastic development and oxidative stress. BMC Cell Biol 2001, 2:16.
55. Saito M., Marumo K., Soshi S., Kida Y., Ushiku C., Shinohara A. Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 2010, 21:655-666.
56. Miyata T., van Ypersele de Strihou C., Kurokawa K., Baynes J.W. Alternations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 1999, 55:389-399.